Ftse Mib
33.921,02
-1,02%
DAX
17.883,36
-1,05%
S&P 500
5.003,97
-1,33%
NASDAQ Composite
15.442,28
-1,72%
Bitcoin
63.259,32
-1,59%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistente personale
Home Investire Azioni Regno Unito LSE Roche Holding Ag (0QQ6) Roche Holding Ag (0QQ6) Notizie

Roche Holding Ag

0QQ6
229,20
0,00 (0,00%)
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: CHF

Ultime notizie

Data Ora Fonte Titolo
24/4/202407:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche sales..
24/4/202407:00UKREG[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der..
19/4/202407:00UKREGFDA approves Roche’s Alecensa as the first adjuvant..
17/4/202408:00UKREGRoche’s subcutaneous OCREVUS one-year data demonstrates..
15/4/202407:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi..
11/4/202407:00UKREGRoche granted FDA Breakthrough Device Designation for blood..
26/3/202417:45UKREGRoche receives FDA approval for the first molecular test to..
12/3/202413:30UKREGRoche Annual General Meeting 2024
12/3/202413:30UKREGAssemblée générale 2024 de Roche
12/3/202413:30UKREGRoche Generalversammlung 2024
05/3/202413:30UKREGRoche and Alnylam report positive topline results from the..
25/2/202420:00UKREGNew England Journal of Medicine publishes Phase III data..
16/2/202417:24UKREGFDA approves Xolair as first and only medicine for children..
01/2/202407:03UKREGNew long-term data for Roche’s Vabysmo show sustained..
01/2/202407:00UKREG[Annonce événementielle au sens de l’art. 53 RC] Roche..
01/2/202407:00UKREG[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche übertrifft..
01/2/202407:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds..
16/1/202407:00GLOBEEuropean Commission approves Roche’s Tecentriq SC, the EU's..
29/12/202322:30GLOBERoche enters into a definitive agreement to acquire..
19/12/202315:40GLOBEFDA grants priority review to Xolair (omalizumab) for..
15/12/202307:15GLOBERoche named among top three most sustainable healthcare..
11/12/202307:00GLOBENew data for Roche’s Columvi and Lunsumio presented at ASH..
09/12/202317:30GLOBENew data reinforce the benefit of early preventative..
08/12/202317:50GLOBERoche's Kadcyla is the first targeted therapy to show..
08/12/202317:45GLOBERoche’s inavolisib combination reduces the risk of disease..
05/12/202307:00GLOBERoche announces positive Phase III results for inavolisib..
04/12/202307:00GLOBERoche enters into a definitive merger agreement to acquire..
27/11/202307:00GLOBERoche expands hepatitis diagnostics portfolio to help..
16/11/202307:00GLOBERoche launches automated serology hepatitis E virus tests,..
14/11/202307:00GLOBERoche’s subcutaneous injection of Tecentriq recommended by..
09/11/202307:00GLOBERoche’s Elecsys NfL test, an important aid for those living..
30/10/202321:01GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche announces..
27/10/202307:00GLOBE[Ad hoc announcement pursuant to Art. 53 LR] FDA approves..
23/10/202313:18IHMARKETNEWSMonday’s Wall Street Highlights: Philips, Chevron,..
23/10/202307:00GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche enters..
19/10/202307:00GLOBE[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche mit gutem..
18/10/202307:03GLOBERoche IL-6 is the first immunoassay approved to aid sepsis..
18/10/202307:00GLOBERoche’s Alecensa reduces the risk of disease recurrence or..
13/10/202315:30GLOBELate-breaking data for Roche’s BTK inhibitor fenebrutinib..
12/10/202307:00GLOBENew data for Roche’s OCREVUS show that after 10 years of..
11/10/202308:00GLOBERoche’s OCREVUS twice-yearly, 10-minute subcutaneous..
10/10/202307:00GLOBERoche’s Vabysmo maintained vision improvements with extended..
04/10/202307:00GLOBEMajority of newborn babies with spinal muscular atrophy..
02/10/202307:00GLOBERoche to present new key clinical and real-world data at..
07/9/202313:00GLOBERoche and Alnylam report positive topline results from Phase..
01/9/202307:00GLOBERoche’s Alecensa delivers unprecedented Phase III results..
29/8/202311:00GLOBERoche’s Tecentriq becomes the first subcutaneous..
29/8/202307:00GLOBEEuropean Commission approves Roche’s Evrysdi for babies..
23/8/202307:22GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche provides..
27/7/202307:00GLOBE[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche verzeichnet..
Apertura: Min: Max:
Chiusura: 229,20

La tua Cronologia

LSE
0QQ6
Roche
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network